The RAD-VACCINE phase 2 trial aimed to provide an update on neoadjuvant sasanlimab and SBRT as an in-situ vaccine for MIBC. The primary objectives are safety, feasibility, and pCR. The trial is ongoing. Raj Satkunasivam and the team conducted a study that aimed to assess the safety and efficacy of combining neoadjuvant immunotherapy […]...
EAU 2024
Coverage of The 39th Annual European Association of Urology Congress 2024
Apr 05
-Apr 08, 2024